SEC Form 4 · accession 0000899243-17-021420
ORASURE TECHNOLOGIES INC · OSUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Smith
Officer — See Remarks
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001116463
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 31, 2017 | M | 9,012 | $9.305 | A | 32,477 | D | |
| COMMON STOCK | Aug 31, 2017 | S | 9,012 | $20.47 | D | 23,465 | D | |
| COMMON STOCK | Aug 31, 2017 | S | 100 | $20.40 | D | 23,365 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NON-QUALIFIED STOCK OPTIONSF1 | $9.305 | Aug 31, 2017 | M | 9,012 | D | — | Feb 3, 2025 | COMMON STOCK | 9,012 | 8,507 | D |
Explanation of responses
- F1Non-Qualified stock options granted on February 3, 2015, vesting and exercisable over a four-year period, with one fourth vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis over the remaining 36 months.
Remarks
EVP, BUSINESS UNIT LEADER, MOLECULAR SOLUTIONS